Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
32 participants
INTERVENTIONAL
2021-03-15
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group P(placebo)
Attach two placebo patches for 12 hours, above and below the incision site.
No interventions assigned to this group
Group L(lidocaine patch)
Attach two lidocaine patches for 12 hours, above and below the incision site.
Group L
Attach two lidocaine patches for 12 hours, one above and below the incision site.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group L
Attach two lidocaine patches for 12 hours, one above and below the incision site.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled open unilateral herniorrhaphy
Exclusion Criteria
* severe renal or hepatic dysfunction
* allergy to amide-based local anesthetic agents
* taking class 1 antiarrhythmic drugs (tocainide and mexiletine, etc.)
19 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SK Chemicals Co., Ltd.
INDUSTRY
BON WOOK KOO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
BON WOOK KOO
associative professor of anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
BON WOOK KOO
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National Universuty, Bundang Hospital
Seongnam-si, Gyonggido, South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ahn HM, Oh HK, Kim DW, Kang SB, Koo BW, Lee PB. Efficacy and safety of 5% lidocaine patches for postoperative pain management in patients undergoing unilateral inguinal hernia repair: study protocol for a prospective, double-blind, randomized, controlled clinical trial. Trials. 2022 Sep 11;23(1):767. doi: 10.1186/s13063-022-06700-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LDPS
Identifier Type: -
Identifier Source: org_study_id